Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
ByHeart logo — Next-Generation Baby Nutrition.

ByHeart

Next-Generation Baby Nutrition.

Founded 2016 United States New York, United States 183 employees Series C Total: $277.00M Biotechnology, Health Care +2

General Information

Company Name ByHeart
Founded Year 2016
Location United States New York, United States +4
Employees 183
Industries Biotechnology, Health Care, Health and Wellness +1
Funding Stage Series C
Social

Get notified when ByHeart moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About ByHeart

ByHeart is a leading infant nutrition startup with a mission to revolutionize baby nutrition. Founded in 2016, the company has made significant strides in the industry, notably as the first new U.S infant formula manufacturer in 15 years. ByHeart's Whole Nutrition Infant Formula, launched in March 2022, is a testament to their dedication to innovation and high standards. With over $250M in funding, including a recent $95.00M Series C investment from AF Ventures, Gaingels, D1 Capital Partners, Polaris Partners, Red Sea Ventures, Bellco Capital, OCV Partners, and Two River, ByHeart is poised for continued growth. The company's commitment to using organic, grass-fed whole milk and pioneering the addition of key breast milk proteins in their formula sets them apart. By conducting the largest clinical trial in 25 years, they have clinically proven the benefits of their formula, including enhanced nutrient absorption and longer stretches between nighttime feeds. With a team of over 275 people across the country, ByHeart is dedicated to creating a future where all parents feel confident about their baby's nutrition choices.

Taxonomy: infant nutrition, baby formula, breast milk science, organic ingredients, clinical trial, clean label, nutrition science, immune health, microbiome health, cognitive health, digestive health, startup, investor, New York, manufacturing facilities

Funding Rounds & Investors (5)

View All
Funding Stage Amount Investors Lead Investors Date
Series C •••••• 8
Investor Investor Investor Investor Investor Investor Investor Investor
13 May 2024
Debt Financing •••••• 1
Investor
01 Mar 2023
Series B •••••• 1
Investor
26 Jul 2021
Series A •••••• - 15 Apr 2020
Debt Financing •••••• - 25 Jun 2019

ByHeart Alternatives & Competitors

ByHeart vs
Care A2+
Care A2+ Australia

Australia's First Premium A2 Formula LED By Science At Care A2+ it’s our mission to care more www.ca...

Private Equity
7 employees
Consumer Goods, Food and Beverage
Compare ByHeart vs Care A2+

FAQ About ByHeart

Next-Generation Baby Nutrition.
ByHeart was founded in 2016.
ByHeart is headquartered in New York, United States.
ByHeart operates in the following industries: Biotechnology, Health Care, Health and Wellness, Nutrition.
ByHeart has approximately 183 employees.
ByHeart has completed 5 funding rounds, raising a total of $277.00M. The latest funding stage is Series C.
Top alternatives and competitors to ByHeart include Care A2+. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
ByHeart and Care A2+ are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors ByHeart and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy